Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing in Brief: L'Oreal

This article was originally published in The Rose Sheet

Executive Summary

L'Oreal: Plentitude Revitalift Eye anti-wrinkle and firming cream is formulated with the firm's exclusive peptide Par Elastyl and pro retinol A to "firm, tone and improve skin's resiliency around the eye area," the company said. The cream also employs a hydrating protein complex of pro vitamin B5, glycerin and soy protein to "reduce fine lines and wrinkles," the Cosmair division added. Soy protein also combats puffiness, while shorea oil provides "essential" fatty acids to "prevent water loss and provide barrier lipids," L'Oreal said. Revitalift Eye is a follow-up to the Revitalift anti-wrinkle and firming cream for the face and neck, which launched in October ("The Rose Sheet" July 17, 1995, Marketing In Brief). The eye cream will be supported under the $9 mil. Revitalift ad umbrella, with print and TV ads breaking in conjunction with the September launch. A 5 oz. jar of Revitalift Eye will sell for $12.99...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel